{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:14:45Z","timestamp":1788315285795,"version":"build-2803163510"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,1]]},"DOI":"10.2146\/ajhp130171","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T22:42:49Z","timestamp":1384814569000},"page":"2105-2109","source":"Crossref","is-referenced-by-count":7,"title":["Management of digoxin therapy using pharmacokinetics in a patient undergoing continuous venovenous hemofiltration"],"prefix":"10.1093","volume":"70","author":[{"given":"Scott T.","family":"Benken","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Chicago Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan D.","family":"Lizza","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Northwestern Memorial Hospital, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Yamout","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cybele","family":"Ghossein","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041607524784600_b1-0702105","volume-title":"Digoxin package insert","year":"2009"},{"key":"2019041607524784600_b2-0702105","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"2019041607524784600_b3-0702105","first-page":"e391","article-title":"2009 Focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"2019041607524784600_b4-0702105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7326\/0003-4819-95-3-283","article-title":"Effect of digoxin on right ventricular function in severe chronic airflow obstruction. A controlled clinical trial","volume":"95","author":"Mathur","year":"1981","journal-title":"Ann Intern Med"},{"key":"2019041607524784600_b5-0702105","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2019041607524784600_b6-0702105","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1161\/CIRCULATIONAHA.105.560110","article-title":"Contemporary use of digoxin in the management of cardiovascular disorders","volume":"113","author":"Gheorghiade","year":"2006","journal-title":"Circulation"},{"key":"2019041607524784600_b7-0702105","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1681\/ASN.2009101047","article-title":"Digoxin associates with mortality in ESRD","volume":"21","author":"Chan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2019041607524784600_b8-0702105","unstructured":"Emit 2000 digoxin assay package insert. www.beckmancoulter.com\/wsrportal\/techdocs?docname=\/cis\/4H072\/%25%25\/EN_DIGOXIN.pdf (accessed 2013 Jul 22)."},{"key":"2019041607524784600_b9-0702105","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/00007691-199612000-00008","article-title":"Enzyme-multiplied immunoassay (Emit 2000) digoxin assay compared with fluorescence polarization immunoassay and Amerlex 125I-radioimmunoassay at two Australian centers","volume":"18","author":"Saccoia","year":"1996","journal-title":"Ther Drug Monit"},{"key":"2019041607524784600_b10-0702105","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1345\/aph.1Q437","article-title":"Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration","volume":"45","author":"Scheetz","year":"2011","journal-title":"Ann Pharmacother"},{"key":"2019041607524784600_b11-0702105","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1128\/AAC.49.6.2421-2428.2005","article-title":"Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients","volume":"49","author":"Fish","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2019041607524784600_b12-0702105","first-page":"346","volume-title":"Critical care medicine: principles of diagnosis and management in the adult","author":"Parrillo","year":"2008"},{"key":"2019041607524784600_b13-0702105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1086\/499535","article-title":"Adjustment of antimicrobial dosages for continuous venovenous hemofiltration based on patient-specific information","volume":"42","author":"Scheetz","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019041607524784600_b14-0702105","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/CCM.0b013e3181dd8364","article-title":"Adverse drug events in intensive care units: risk factors, impact, and the role of team care","volume":"38","author":"Kane-Gill","year":"2010","journal-title":"Crit Care Med"},{"key":"2019041607524784600_b15-0702105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(00)02430-2","article-title":"Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: a prospective randomised trial","volume":"356","author":"Ronco","year":"2000","journal-title":"Lancet"},{"key":"2019041607524784600_b16-0702105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2165\/00003088-199324050-00002","article-title":"Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations","volume":"24","author":"Reetze-Bonorden","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"2019041607524784600_b17-0702105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1345\/aph.17105","article-title":"A primer on continuous renal replacement therapy for critically ill patients","volume":"32","author":"Joy","year":"1998","journal-title":"Ann Pharmacother"},{"key":"2019041607524784600_b18-0702105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/15563650903544132","article-title":"Massive ingestion of cardiac drugs: toxicokinetic aspects of digoxin and sotalol during hemofiltration","volume":"48","author":"Mulder","year":"2010","journal-title":"Clin Toxicol"},{"key":"2019041607524784600_b19-0702105","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/08860227709037664","article-title":"Elimination of cardiac glycosides through hemofiltration","volume":"1","author":"Kramer","year":"1977","journal-title":"J Dial"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/70\/23\/2105\/28456393\/ajhp2105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T08:00:42Z","timestamp":1555401642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/70\/23\/2105\/5112413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":19,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp130171","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,12,1]]},"published":{"date-parts":[[2013,12,1]]}}}